James Snodgrass

London, UK

Email: james.snodgrass@bairdscmc.com
Linkedin: jamessnodgrass

With over two decades of experience in the health and development field, James Snodgrass offers exceptional expertise in health policy research and development, global product positioning, communications planning, stakeholder and donor relationships, demand forecasting, and advocacy. He is adept at using diverse data to inform health communication strategies to influence the highest levels of health policy decision-making.

James’ area of specialisation is vaccines and his expertise has been used by the Bill & Melinda Gates Foundation, the AERAS TB Vaccine Foundation, the Hewlett Foundation, and the John Hopkins School Bloomberg School of Public Health, amongst others. He has worked on accounts for leading global health organisations, including the Rockefeller Foundation and the International HIV/AIDS Alliance, and an extensive portfolio of pharmaceutical clients, including Merck & Co, Abbott, Roche, Schering Plough, and Ferring. James also worked with Sir Brian Jarman at Imperial College, London, to develop benchmarking systems for quality of care that are now used extensively in health systems throughout the world

Role:

• Associate at Baird’s CMC

Areas of expertise:

Vaccination; health and development (both in industrialised and developing countries)

Key skill sets:

Policy analysis; communications/messaging; advocacy programs

Services offered:

• Policy research and analysis in health – global capability
• Effective advocacy and communications programs with healthcare leaders throughout the developed and developing world
• Facility and expertise in using diverse data sources to present compelling arguments for health advocacy
• Extensive knowledge and understanding of healthcare systems in Europe and sub-Saharan Africa

Project examples:

• Work on a pan-European policy project to improve evidence-led treatment access for people with opioid dependence
• Support for the Hewlett Foundation in ensuring that high-quality research has an impact on policy and funding for population programs in poor countries

Client examples:

AERAS TB Vaccine Foundation, the Bill & Melinda Gates Foundation, the Hewlett Foundation, the John Hopkins Bloomberg School of Public Health, the International AIDS Vaccine Initiative, PATH, and Merck & Co., Inc.